APPLIED ENVIRONMENTAL MICROBIOLOGY, Sept. 2011, p. 6133â€“6140                                                              Vol. 77,  17
0099-2240/11/$12.00 doi:10.1128/AEM.00630-11
Copyright Â© 2011, American Society Microbiology. Rights Reserved.



          Determining Extremes Cellular NAD(H) Level             Using Escherichia coli NADâ«¹-Auxotrophic MutantäŒ¤
  Yongjin Zhou,1,3 Lei Wang,1,3 Fan Yang,1 Xinping Lin,1,3 Sufang Zhang,1 Zongbao K. Zhao1,2*
Dalian Institute Chemical Physics, Chinese Academy Sciences, Dalian 116023, Peopleâ€™s Republic China1; Dalian National
              Laboratory Clean Energy, Dalian 116023, Peopleâ€™s Republic China2; Graduate University                            Chinese Academy Sciences, Beijing 100049, Peopleâ€™s Republic China3
                                               Received 21 March 2011/Accepted 28 June 2011

             NAD (NADâ´™) reduced form (NADH) omnipresent cofactors biological systems.            difficult determine extremes cellular NAD(H) level live cells NADâ´™ level tightly
          controlled biosynthesis regulation mechanism.  developed strategy determine extreme
          NAD(H) levels Escherichia coli cells genetically engineered NADâ´™ auxotrophic.            expressed ntt4 gene encoding NAD(H) transporter E. coli mutant YJE001, deletion
          nadC gene responsible NADâ´™ novo biosynthesis, showed NTT4 conferred mutant
          strain better growth presence exogenous NADâ´™. constructed NADâ´™-auxotrophic mutant
          YJE003 disrupting essential gene nadE, responsible step NADâ´™ biosynthesis           cells harboring ntt4 gene. minimal NADâ´™ level determined M9 medium proliferating YJE003
          cells preloaded NADâ´™, maximal NAD(H) level determined exposing
          cells high concentrations exogenous NAD(H). Compared supplementation NADH, cells
          grew faster higher intracellular NAD(H) level NADâ´™ fed. intracellular NAD(H)
          level increased increase exogenous NADâ´™ concentration, reached plateau.            minimal NAD(H) level 0.039 mM maximum 8.49 mM determined, 0.044â´›           9.6â´› wild-type cells, respectively. Finally, potential application strategy biotech-
          nology briefly discussed.


   NAD (NADâ«¹; reduced state NADH) plays                              inner membrane, NADâ«¹ se im-
essential role cellular metabolism function                 permeable bacterial cytoplasmic membrane (Fig. 1B)
cofactor 300 redox reactions (10).  NADâ«¹                      (21). NADâ«¹ transporter, NTT4, discovered level NADH/NADâ«¹ ratio determine metabolic                          prokaryote chlamydial endosymbiont Protochlamydia
fluxes pathways transcriptional level                   amoebophila UWE25, transport intact NAD(H) genes vivo (13, 14). example, high NADH/                      counterexchange ADP (11). Recently, NADâ«¹
NADâ«¹ ratio triggers overflow metabolism (33), low                        carriers located chloroplasts mitochondria NADH/NADâ«¹ ratio enhances glycolytic flux (38).                             discovered eukaryotes Saccharomyces cerevisiae Manipulating NADH/NADâ«¹ ratio considered                          Arabidopsis thaliana (20, 28). transporters import effective strategies improving productivity                   NADâ«¹, counterexchange nucleotides (ADP, AMP, products (19, 23). metabolic path-                       GMP), cells organelles lack NADâ«¹ biosynthesis
ways NADâ«¹ biosynthesis Escherichia coli, novo                    capacity support biological process (Fig. 1B).
pathway salvage pathway (3, 15). novo path-                        level intracellular NAD(H) tightly controlled way starts oxidation aspartate iminosuccinic                    variety mechanisms, including biosynthesis sal-
acid, catalyzed NadB turn reacts                       vage NadR regulation (10). internal
dihydroxyacetone phosphate quinolinic acid (QA),                       NAD(H) level low, NadR interacts integral mem-
followed phosphoribosylation decarboxylation,                        brane protein PnuC, responsible transport
sulting nicotinic acid mononucleotide (NAMN). sal-                      NMN cytoplasmic membrane, promoting net
vage pathway converts precursors (nicotinic acid                       NMN transportation cell. NAD(H) level
[NA], nicotinamide [NM], nicotinamide mononucle-                           increases, NadR binds operator regions target
otide [NMN]) NAMN, converted                            genes (nadA, nadB, pncB) represses transcrip-
NADâ«¹ adenylation amidation catalyzed                            tion decrease biosynthesis.  studies
NadD NadE, respectively (Fig. 1A). Like                        succeeded enhancing NAD(H) pool manip-
precursors, NA, NMN taken                           ulating biosynthetic pathway regulation
medium (25);  extracellular NADâ«¹ degraded                         overexpression pncB control
NMN adenosine periplasm passing                              native operator promoter sequences, intra-
                                                                               cellular NAD(H) increased 5-fold cells cultured
                                                                               presence 0.1 mM exogenous nicotinic acid (34).
   * Corresponding author. Mailing address: Dalian Institute Chem-
ical Physics, CAS, Dalian 116023, Peopleâ€™s Republic China. Phone
                                                                               pncB mutated operator region protect fax: 86-411-84379211. E-mail: zhaozb@dicp.ac.cn.                           regulatory effect NadR overexpressed
   äŒ¤
     Published ahead print 8 July 2011.                                  lac promoter, resulting 2.2-fold increase 
                                                                        6133
 6134     ZHOU ET AL.                                                                                              APPL. ENVIRON. MICROBIOL.




   FIG. 1. Overview NADâ«¹ metabolism.   NADâ«¹ biosynthetic salvage pathways E. coli. (B) Schematic representation linkage NADâ«¹ biosynthesis transport pathway. Dashed lines NADâ«¹ transport model chloroplasts mitochondria,
discovered eukaryotes S. cerevisiae  thaliana; solid lines refer NADâ«¹ metabolic pathway transport pathway prokaryotes E.
coli Chlamydia, respectively. Abbreviations: ASP, asparate; DHAP, dihydroxyacetone phosphate; ImASP, imino asparate; QA, quinolinate;
NA, nicotinate; NM, nicotinamide; NMN, nicotinamide mononucleotide; NmR, nicotinamide ribonucleoside; NaR, nicotinate ribonucleoside;
NAMN, nicotinic acid mononucleotide; dNAD, deamino NADâ«¹; Ade, adenosine. Enzymes: NadB, L-aspartate oxidase; NadA, quinolinate
synthetase; NadC, quinolinate phosphoribosyltransferase; NadD, NAMN adenyltransferase; NadE, NADâ«¹ synthetase; UshA, NMN glycohydro-
lase; DeoD, purine-nucleoside phosphorylase PncA, Nm deamidase; PncB, NA phosphoribosyltransferase; NudC, NADâ«¹ pyrophosphatase; NadK,
NADâ«¹ kinase. ScNDT1 ScNDT2, NADâ«¹ carriers NDT1 NDT2 S. cerevisiae; AtNDT1 AtNDT2, NADâ«¹ carriers NDT1 NDT2  thaliana.


 NAD(H) level (22). Cooverexpression pncB                   study, manipulated NAD(H) level feeding
nadE gene led dramatic 7-fold increase                   NAD(H) NADâ«¹-auxotrophic E. coli mutant NAD(H) level (12). NAD(H) level reduced                      constructed disrupting essential gene nadE, nadD mutation, encoded NAMN adeny-                     responsible step NADâ«¹ biosynthesis cells
lyltransferase (25).                                                      NADâ«¹ transporter NTT4 expression background.
   NAD(H) pool adjusted manipu-                    led successful determination extremes lating biosynthetic pathway, remains difficult inves-           intracellular NAD(H) level. Finally, discuss potential
tigate effects extremes NAD(H) level cell                application results fields biotechnology 
growth corresponding self-regulation mechanism.                lated cofactor engineering.
 VOL. 77, 2011                                                                           EXTREMES CELLULAR NAD(H) LEVEL                                   6135


                                                    TABLE 1. Strains plasmids used study
 Strain plasmid                                                 Genotype characteristic                                                Resource reference

E. coli strains
  DH5â?£                         Fâ«º â?¾80dlacZâŒ¬M15 âŒ¬(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rkâ«º mkâ«¹) phoA supE44                                     TaKaRa
                                  â?­â«º thi-1 gyrA96 relA1
  BW25113                      rrnB3 âŒ¬lacZ4787 hsdR514 âŒ¬(araBAD)567 âŒ¬(rhaBAD)568 rph-1                                                             8
  JW0105                       BW25113/nadC::kan                                                                                                   2
  YJE001                       BW25113/nadC::kan/pET15b-NTT4                                                                                       study
  YJE002                       BW25113/pKD46/pET15K-NTT4                                                                                           study
  YJE003                       BW25113/pET15K-NTT4/nadE::cat                                                                                       study

Plasmids
  pMD18-T                      lacZ pBR322 ori bla; cloning vector                                                                                 TaKaRa
  pET15b                       T7 promoter, lacI pBR322 ori bla                                                                                    Novagen
  pET15b-NTT4                  ntt4 inserted NdeI-BamHI site, NTT4 expression, bla                                                              study
  pET15K-NTT4                  ntt4 inserted NdeI-BamHI site, NTT4 expression, kan                                                              study
  pKD3                         oriR6Kâ?¥ bla cat rgnB(Ter)                                                                                           8
  pKD4                         oriR6Kâ?¥ bla kan rgnB(Ter)                                                                                           8
  pKD46                        araBp-gam-bet-exo bla repA101(Ts) oriR101                                                                           8



                          MATERIALS METHODS                                      Briefly, reaction mixture consisted plasmid (200 ng), megaprimer
                                                                                    Kan (600 ng), 5â«» PrimeSTAR buffer (10 â?®l), 2.5 mM deoxynucleoside triphos-
   Bacterial strains plasmids. Cloning plasmid propagation 
                                                                                    phates (6 â?®l), PrimeSTAR HS DNA polymerase (1.25 U) total volume 50
formed E. coli DH5â?£. E. coli BW25113(pKD3, pKD4, pKD46) kindly
                                                                                    â?®l. thermocycling conditions 95Â°C 5 min, 35 cycles 95Â°C 1
provided B. L. Wanner (Purdue University). E. coli JW0105 obtained
                                                                                    min, 55Â°C 45 s, 68Â°C 6 min, final 68Â°C 20 min. reaction KEIO knockout collection E. coli BW25113 background
(2). strains plasmids used listed Table 1.                        mix treated DpnI 37Â°C 4 h digest methylated parental
   Growth media conditions. E. coli routinely cultivated agitation     plasmid transformed E. coli DH5â?£ competent cells. 37Â°C 30Â°C  gene disruption) 200 rpm LB broth (10 g             nadE 200-bp flanking regions amplified E. coli BW25113
tryptone [Oxoid], 5 g yeast extract [Oxoid], 10 g NaCl liter water), SOB        genomic DNA using primer pair nadE-F/nadE-R cloned broth (20 g tryptone [Oxoid], 5 g yeast extract [Oxoid], 0.5 g NaCl, 2.5 mM         pMD18-T. Disruption cassettes nadE constructed replacing nadE
KCl, 1 mM MgCl2, 1 mM MgSO4 liter water), M9 minimal medium (6               cat amplified pKD3 primer pair cat(E)-F/cat(E)-R, resulting
g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl, 1 mM MgSO4, 0.1 mM                    pMD18T-nadE::CAT.
CaCl2 liter water) containing 2  glucose, 1,000â«» trace metal mix (27           Deletion nadE performed described previously (8) minor
g FeCl3 ä¡  6H2O, 2 g ZnCl2 ä¡  4H2O, 2 g CaCl2 ä¡  2H2O, 2 g Na2MoO4 ä¡  2H2O,             modification. nadE disruption cassette nadE::CAT PCR amplified 1.9 g CuSO4 ä¡  5H2O, 0.5 g H3BO3 liter water). strains inocu-           pMD18T-nadE::CAT prime pair nadE-F/nadE-R transformed
lated overnight cultures 37Â°C, washed 2 times M9 medium,           E. coli YJE002 electroporation. mutants selected SOB
transferred 50 ml M9 medium supplemented NAD(H)                  plates supplemented kanamycin sulfate (50 â?®g/ml), chloramphenicol (30
optical density 600 nm (OD600) 0.02. Samples regularly taken         â?®g/ml) NADâ«¹ (100 â?®M).
measurement OD600 NAD(H).                                                   Cofactor measurements. Cofactor recycling assay used determine 
   Reagents. Pfu DNA polymerase supplied Tiangen Biotech (Beijing,           tracellular concentrations NAD(H) NADP(H) minor modifications
China). primers used study (Table 2) purchased Invitrogen     (7, 22). assay, 5 â«» 109 cells collected centrifugation (Shanghai, China), DNA sequencing performed TaKaRa (Dalian,              8,000 â«» g 2 min cell pellets washed twice ice-cold phos-
China). DNA gel purification kit plasmid extraction kit purchased        phate-buffered saline (PBS) buffer.  300 â?®l 0.2 M NaOH  NAD(P)H Beyotime (Haimen, China). DpnI purchased New England Bio-             extraction] HCl  NAD(P)â«¹ extraction] added cell pellets,
Labs (Beijing, China), PrimeSTAR HS DNA polymerase                heated 10 min 55Â°C. extracts neutralized reagents purchased TaKaRa (Dalian, China). chemicals             adding 300 â?®l 0.1 M HCl  NAD(P)H extraction] NaOH  purchased Sigma (Shanghai, China).                                             NAD(P)â«¹ extraction]. cellular debris removed centrifuging    DNA manipulation. ntt4 gene (11) custom synthesized TaKaRa            12,000 â«» g 5 min. Supernatants transferred new tubes stored
(Dalian, China) cloned NdeI-BamHI site pET15b         â«º20Â°C 24 h.
primer pair NTT4-F/NTT4-R, resulting NTT4 expression vector pET15b-             cycling assay performed using reagent mixture consisting equal
NTT4. pET15K-NTT4 constructed substituting bla gene kan             volumes 1.0 M Bicine buffer (pH 8.0), absolute ethanol  NAD(H)
amplified Kan-F/Kan-R, using restriction-free (RF) cloning strategy        assay] 30 mM glucose-6-phosphate  NADP(H) assay], 40 mM EDTA
(32). RF cloning experiment according procedure described       (pH 8.0), 4.2 mM 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-



                                                            TABLE 2. Primers used study
 Primer                                                             Sequence (5â¬˜â€“3â¬˜                                                                 Function

NTT4-F                GAGCATATGAGTAAAACAAACCAG                                                                                                   ntt4 cloning
NTT4-R                TACGGATCCTTAGTGATGATGATGATGATGTTTTTTTATAAAAG
Kan-F                 TTAAACATGCCAGTGATGCAAAGGTAGTGCAAGAGCTATGACATATACCTGCCGTTCAC                                                                kan cloning
Kan-R                 TCAGGCGGTCAGTGTATCATCACTCATACTCTGCCCGACACCATGGTCATAGCTGTTTC
nadE-F                GTTAATACCGCCGCTGCACTCAG                                                                                                    nadE cloning
nadE-R                TCACCATGAAACAGATACACCCCTG
cat(E)-F              TGTCTTTTCTGTCTGGAGGGGTTCAATGATGGGAATTAGCCATGGTCC                                                                           cat amplification
cat(E)-R              CAAATTATTACTTTTTCCAGAAATCATCGTGTAGGCTGGAGCTGCTTC
        restriction sites underlined.
 6136       ZHOU ET AL.                                                                                                       APPL. ENVIRON. MICROBIOL.

mide, twice volume 16.6 mM phenazine ethosulfate, 3 volumes water, previously incubated 25Â°C. following volumes added 1-ml
cuvettes: 50 â?®l neutralized extract, 0.9 ml reagent mixture. NAD(H)
assay, reaction started adding 50 â?®l yeast ADH II (500 U/ml Bicine buffer). Fifty microliters yeast glucose-6-phosphate dehydrogenase (10
U/ml) added start NADP(H) assay. absorbance 570 nm recorded 2 min 25Â°C. volume cell 10â«º12 ml, cell
concentrations calculated based assumption OD600 1.0
corresponds 109 cells/ml (5);  cell density correlated cell
volume, 1 ml/liter equivalent OD600 1.
   Determination minimal NAD(H) level. colonies NADâ«¹-auxo-
trophic mutant YJE003 picked LB medium containing 100 â?®M NADâ«¹ cultivated 12 h agitation 37Â°C, 200 rpm.  cells inoculated 100 ml M9 medium supplemented 100 â?®M NADâ«¹ OD600 0.02 cultivated early exponential phase (OD600, â¬‡0.8). cells collected washed twice M9 medium inoculated 50 ml M9 medium, initial OD600 0.1, 0.2, 0.3, respectively, cultivated stationary phase, cofactor level minimal
level E. coli growth. cells collected washed ice-cold PBS
buffer used intracellular NAD(H) measurements.
   Determination maximal NAD(H) level. NADâ«¹-auxotrophic mu-
tant YJE003 picked LB medium containing 100 â?®M NADâ«¹ cultivated 12 h agitation 37Â°C, 200 rpm. cells collected washed twice M9 medium, inoculated 50 ml M9 medium
supplemented different concentrations NADâ«¹, initial OD600 0.02 cultivated agitation 37Â°C, 200 rpm stationary phase. cells used intracellular NAD(H) measurements washing twice ice-cold PBS buffer.


                                  RESULTS
                                                                                       FIG. 2. Verification function NTT4 âŒ¬nadC mutant.
   Verification NTT4 function âŒ¬nadC mutant.                                  NTT4 function verified expressing E. coli JW0105,
NAD(H) se impermeable bacterial cytoplasmic                            lacks novo NADâ«¹ biosynthesis pathway nadC
                                                                                     disruption. (B) NTT4-expressing strain YJE001 better growth membrane (1, 21), usually intermediates,                         control strain cultivated M9 medium containing 100 â?®M AMP, NMN, NA, directly assimilated. Recently,                          NADâ«¹. NADâ«¹ transporter, NTT4, discovered chlamyd-
ial endosymbiont P. amoebophila UWE25 (11). properties transporter studied cloning ntt4 gene E.                    BW25113 obtained disruption nadE gene obtain
coli analyzing transportation activity 32P-labeled                      NADâ«¹-auxotrophic mutant YJE003. mutant strain
nucleotides cells resting state.  remains                      grew LB plates supplemented NADâ«¹ unknown transportation activity NTT4 suf-                         NADH failed grow plates NADâ«¹ intermediates,
ficient support cell growth exogenous NADâ«¹.                             NA NMN (Fig. 3B).
structed E. coli YJE001, ntt4 gene expressed                           Comparison cofactor levels exogenous
E. coli JW0105, strain lacks novo NADâ«¹ biosyn-                         NADâ´™- NADH-fed cells. previous study showed thesis pathway nadC disruption (Fig. 2A).                        NTT4 transport NADâ«¹ NADH YJE001 grew 20  faster exponential phase                        NADH uptake rate little lower resting cells (11), presence NADâ«¹ medium (Fig. 2B),                              growing cells NTT4 transportation activity differences
wild-type BW25113 cells insensitive exogenous NADâ«¹                           NADâ«¹ NADH remained undetermined. 
(data shown), suggesting NTT4 protein func-                         fore, examined effects concentration exoge-
tional NADâ«¹ transporter E. coli. surmised                       nous NADâ«¹ NADH intracellular cofactor levels activity NTT4 able rescue cells NADâ«¹                         cell growth profile. turned cells grew
biosynthesis completely blocked. test conjecture,                        faster fed NADâ«¹, instead NADH. cells fed NADâ«¹, decided disrupt essential gene nadE,                           total intracellular NAD(H) levels 4.82 mM 14 h volved step NADâ«¹ biosynthesis.                                        7.55 mM 26 h, higher levels    Construction NADâ´™-auxotrophic mutant nadE dis-                          fed NADH (Table 3). results sug-
ruption. order manipulate intracellular NADâ«¹ level,                        gested NTT4 prefers NADâ«¹ NADH,  attempted remove NADâ«¹ regulation effect dis-                            sistent results observed using resting cells (11). rupting essential gene nadE, responsible                        NADâ«¹/NADH ratio higher NADâ«¹- step NADâ«¹ biosynthesis.  impractical                        fed cells NADH-fed cells, indicating NADâ«¹-fed cells did access exogenous NADâ«¹ (2).                           cells higher oxidative state.
âŒ¬nadC mutant carrying ntt4 gene showed advantageous                              Determination minimal cofactor level E. coli cell
growth profile presence exogenous NADâ«¹,                                 proliferation. studies successfully perturbed thought possible construct NADâ«¹-auxotro-                           intracellular cofactor level, especially increasing NADâ«¹
phic mutant NTT4 expression background gener-                             level (34) manipulation NADâ«¹/NADH ratio (22),
ated (Fig. 3A).  expressed ntt4 gene E. coli                          difficult determine minimal cofactor level  VOL. 77, 2011                                                                   EXTREMES CELLULAR NAD(H) LEVEL                           6137




   FIG. 3. Construction characterization NADâ«¹-auxotro-
phic mutant YJE003.   NADâ«¹-auxotrophic mutants 
structed disrupting nadE gene NTT4 expression 
ground. (B) Phenotype NADâ«¹-auxotrophic mutant YJE003. 109 overnight cultured cells suspended 1 ml double-
distilled H2O (OD600, 0.1), 10-â?®l aliquots dilutions 10â«º1        FIG. 4. Determination minimal cofactor level cell
10â«º6 spotted corresponding plates  left right).          growth, based NADâ«¹ distribution strategy NADâ«¹-
                                                                             auxotrophic mutant YJE003.   Schematic NADâ«¹ distribution
                                                                             strategy. auxotrophic mutant YJE003 preloaded certain
                                                                             NADâ«¹ cultivating M9 medium containing 100 â?®M
                                                                             NADâ«¹ early log phase (OD600, â¬‡0.8), washed twice M9 
cell proliferation. NADâ«¹ level regulated
                                                                             dium, transferred M9 medium NADâ«¹. cells NADâ«¹ biosynthesis pathways, activated supply                 proliferated, cofactor distributed daughter cells NADâ«¹ NADâ«¹ level low. NADâ«¹-auxo-                         cellular cofactor limited cell division. (B) Growth curve trophic mutant, minimal cofactor level cell growth                   YJE003 M9 medium NADâ«¹ different inoculation determined based NADâ«¹ distribution strategy                  densities (0.1 0.3). (C) Intracellular cofactor concentrations                                                                              measured cells reached stationary phase. data
(Fig. 4A), inspired plasmid distribution                    represent averages â«¾ standard deviations model (31). Briefly, auxotrophic mutant YJE003 pre-                  independent samples.
loaded certain NADâ«¹ transferred minimal medium NADâ«¹. cells divided cofactor distributed daughter cells cel-              0.3, maximal OD600 1.7 (Fig. 4B), lular cofactor level reached minimum limited cell                   lower OD600 2.7 obtained YJE003 cells
division. interesting matter initial              cultivated presence 100 â?®M NADâ«¹ (Fig. 5A).
OD600 0.1, 0.2, 0.3, YJE003 cells reached stationary              observations suggested cofactor level 
phase cultivation 4 h, cell density                  deed limiting cell division.
increased 4-fold. example, initial OD600                    cell density YJE003 increased 4-fold M9 


                            TABLE 3. Intracellular NAD(H) levels E. coli YJE003 cells fed 100 â?®M NADâ«¹ NADH
                                                                           Intracellular levela (mM)
 Feed                   Duration (h) feeding                                                                                   NADâ«¹/NADH ratio
                                                          NADâ«¹                     NADH                    NAD(H)

NADâ«¹                              14                   4.26 â«¾ 0.55               0.56 â«¾ 0.09             4.82 â«¾ 0.62                     7.66
                                  26                   6.23 â«¾ 0.13               1.32 â«¾ 0.10             7.55 â«¾ 0.17                     4.72

NADH                              14                   2.21 â«¾ 0.21               0.41 â«¾ 0.12             2.62 â«¾ 0.32                     5.33
                                  26                   2.46 â«¾ 0.06               0.68 â«¾ 0.04             3.14 â«¾ 0.09                     3.63
        Values means â«¾ standard deviations.
 6138      ZHOU ET AL.                                                                                                      APPL. ENVIRON. MICROBIOL.


                                                                             â?®M, respectively. total NAD(H) level reached ex-
                                                                             tremely high value 8.49 mM initial feeding NADâ«¹
                                                                             concentration 1 mM (Fig. 5B), 9.6-fold                                                                              wild-type cells.


                                                                                                           DISCUSSION
                                                                                previous study, NTT4 chlamydial P. amoebophila
                                                                             UWE25 expressed E. coli characterized                                                                              NADâ«¹ transporter incubating resting recombinant E.
                                                                             coli cell 32P-labeled nucleotides (11), means                                                                              determine effect transport NADâ«¹ growing cells
                                                                             remained unavailable. present study, confirmed
                                                                             function NTT4 E. coli disrupting nadC gene,
                                                                             responsible novo biosynthesis NADâ«¹
                                                                             (Fig. 2). showed NADâ«¹ transportation
                                                                             activity NTT4 support cell growth fully, depending                                                                              uptake extracellular NADâ«¹ (Fig. 3). known                                                                              disruption essential genes nadD nadE prohibitive
                                                                             (2, 25), successful used E. coli strain    FIG. 5. Manipulation intracellular NAD(H) level dif-          carried ntt4 gene (Fig. 3B).  strategy ferent exogenous NADâ«¹ feeding levels.   Growth curve YJE003             explored alternative identification NADâ«¹
cultivated M9 medium containing different concentrations               transporter utilization radioactive nucleotides. NADâ«¹. â?® growth rate (hâ«º1), calculated linear slopes logarithmic plots growth curves. (B) Intracellular   used identify characterize NADâ«¹
NAD(H) concentrations measured 24 h cells reached                biosynthetic pathways, recently discovered stationary phase. data represent averages â«¾ standard devia-          Francisella tularensis (24). ATP essential energy cofactor
tions independent samples.                                determines energy metabolism metabolic flux
                                                                             (17). ATP transporters identified het-
                                                                             erologously expressed E. coli (27, 29, 30). extremes dium NADâ«¹ supply, estimated total cofactor                 cellular ATP levels determined using similar
level reduced 20  parent                  strategy. impacts extreme cofactor levels cells. results cofactor measurements consistent              metabolism, transcriptome, interactions cofactor expectations. total NAD(H) NADP(H) level                    enzyme (35) investigated future, 0.12 mM, 20  parent cells                    studies new insights microbial cell biology.
(Fig. 4C) 10  wild-type BW25113 cells.                     level NAD tightly controlled variety mech- NAD(H) level 0.04 mM, 4.4                       anisms, including biosynthesis salvage. Studies wild-type cells (Fig. 4C Table 4). cellular              successfully manipulated NADâ«¹ level overexpressing
NADP(H) level 0.08 mM, 50  20                        pncB changing activity NAMN adenylyltransferase parent cells wild-type cells, respectively               constructing nadD mutant library (25, 26).  (Fig. 4C). pointed NAD(H) levels                extremes NAD(H) level, e., minimal maximal wild-type cells consistent previous report (9),              level, remain undetermined live E. coli cells. 
indicating data accurate.                                      structed NADâ«¹-auxotrophic mutant NADâ«¹ bio-
   Determination maximal cofactor level live E. coli               synthesis completely blocked, designed NADâ«¹
cells. NADâ«¹-auxotrophic mutant, minimal cofac-                  distribution strategy determine minimal NADâ«¹ level tor determined cell division strategy.                  cell growth (Fig. 4). mutant strain YJE003, does NAD(H) level change response concentra-                   showed minimal NAD(H) level 4.4  tion exogenous NADâ«¹? maximal NAD(H) level                      wild-type cells. demonstrated 20  total live E. coli cells uphold? order answer                 cellular NAD(H) wild-type cells freely accessible questions, cultivated YJE003 cells presence NADâ«¹ different concentrations (10 â?®M 10 mM). lag
phase cells decreased increases exogenous                 TABLE 4. Intracellular NAD(H) levels NADâ«¹-auxotrophic
NADâ«¹ concentration, growth rate exponential                               mutant YJE003 wild-type E. coli
phase remained (5.1 5.3 hâ«º1). suggested                                                                                                                   NAD(H) level (mM higher NADâ«¹ transportation rate resulting higher                  Cofactor
exogenous NADâ«¹ concentration beneficial early                                        Maximal                  Minimal          Wild type
stage cell growth advantages exponential                   NADâ«¹              7.50 â«¾ 0.10           0.019 â«¾ 0.002        0.64 â«¾ 0.04
growth (Fig. 5A). intracellular NAD(H) levels increased                  NADH              0.99 â«¾ 0.15           0.020 â«¾ 0.004        0.24 â«¾ 0.01 increase initial exogenous NADâ«¹ concentration reached maxima 7.50 mM NADâ«¹ 1.51 mM NADH                          Total             8.49 â«¾ 0.24           0.039 â«¾ 0.002        0.88 â«¾ 0.02 initial feeding NADâ«¹ concentration 1 mM 60                                                                                                       Data means â«¾ standard deviations.
 VOL. 77, 2011                                                             EXTREMES CELLULAR NAD(H) LEVEL                                     6139


majority (80 ) bound enzymes (35). fact             thank National BioResource Project (NIG, Japan) providing
minimal NAD(H) level mutant strain far lower           âŒ¬nadC mutant JW0106 KEIO Collection Barry L. Wan-
                                                                       ner (Purdue University) providing E. coli BW25113(pKD3, pKD4, freely accessible NAD(H) level wild-type cells suggests         pKD46). binding affinity NAD(H) enzymes higher observed previously.  min-                                             REFERENCES
imal cellular NADP(H) level 2-fold minimal              1. Adler, L. W., B. P. Rosen. 1977. Functional mosaicism membrane
NAD(H) level, NADP(H) level lower                   proteins vesicles Escherichia coli. J. Bacteriol. 129:959â€“966.
                                                                        2. Baba, T., et al. 2006. Construction Escherichia coli K-12 frame, single-
NAD(H) level wild-type cells (Fig. 4C), indicating E.              gene knockout mutants: Keio collection. Mol. Syst. Biol. 2:2006.0008.
coli cells need NADP(H) biosynthesis biomass                3. Begley, T. P., C. Kinsland, R.  Mehl,  Osterman, P. Dorrestein. 2001.
precursors cofactor starvation state, NADP(H)                biosynthesis nicotinamide adenine dinucleotides bacteria. Vitam.
                                                                           Horm. 61:103â€“119. main electron carrier anabolism (4).                             4. Blank, L. M., B. E. Ebert, K. Buehler, B. Buhler. 2010. Redox bioca-
   studies, cellular cofactor concentration             talysis metabolism: molecular mechanisms metabolic network anal- increased manipulating NADâ«¹ biosynthetic                  ysis. Antioxid. Redox Signal. 13:349â€“394.
                                                                        5. Brumaghim, J. L., Y. Li, E. Henle, S. Linn. 2003. Effects hydrogen
pathway (12, 16) feeding permeabilized cells (18, 36, 37).              peroxide nicotinamide nucleotide metabolism Escherichia coli: NAD(H) level increased 6-fold previously (12).               changes enzyme levels nicotinamide nucleotide pools studies                                                                            oxidation NAD(P)H Fe(III). J. Biol. Chem. 278:42495â€“42504.  maximal NAD(H) level live cells               6. Buhler, B., J. B. Park, L. M. Blank,  Schmid. 2008. NADH availability
tolerate? address fundamental question, increased               limits asymmetric biocatalytic epoxidation growing recombinant Esche- intracellular NAD(H) level exposing NADâ«¹-auxo-                  richia coli strain. Appl. Environ. Microbiol. 74:1436â€“1446.
                                                                        7. Chemler, J. ,  L. Fowler, K. P. McHugh, M.  Koffas. 2009.
trophic mutant YJE003 cells higher exogenous NADâ«¹                   Improving NADPH availability natural product biosynthesis Esche-
centrations M9 medium. observed 9.6-fold                    richia coli metabolic engineering. Metab. Eng. 12:96â€“104.
crease NAD(H) level compared wild-type            8. Datsenko, K. , B. L. Wanner. 2000. step inactivation chromo-
                                                                           somal genes Escherichia coli K-12 using PCR products. Proc. Natl. Acad.
BW25113 cells presence 1 mM exogenous NADâ«¹.                      Sci. U. S.  97:6640â€“6645. intracellular NAD(H) level did increase            9. Dhamdhere, G., H.  Zgurskaya. 2010. Metabolic shutdown Esche-
exogenous NADâ«¹ concentrations 10 mM, indicating                 richia coli cells lacking outer membrane channel TolC. Mol. Microbiol.
                                                                           77:743â€“754. maximal NAD(H) level E. coli 8.49 mM (Fig.           10. Foster, J. W., Y. K. Park, T. Penfound, T. Fenger, M. P. Spector. 1990.
5B). wild-type cells, NADâ«¹ biosynthesis repressed            Regulation NAD metabolism Salmonella typhimurium: molecular se-
                                                                           quence analysis bifunctional nadR regulator nadA-pnuC
salvage NADâ«¹ degradation activated intracel-               operon. J. Bacteriol. 172:4187â€“4196.
lular NAD(H) level high. contrast, NADâ«¹ transportation           11. Haferkamp, , et al. 2004. candidate NADâ«¹ transporter intracellular mutant strain YJE003 likely independent                  bacterial symbiont related chlamydiae. Nature 432:622â€“625.
                                                                       12. Heuser, F., K. Schroer, S. Lutz, S. Bringer-Meyer, H. Sahm. 2007.
biosynthesis regulation mechanism, leading accumulation              Enhancement NAD(P)(H) pool Escherichia coli biotransforma-
intracellular NAD(H) high level.                                 tion. Eng. Life Sci. 7:343â€“353.
                                                                       13. Holm,  K., et al. 2010. Metabolic transcriptional response cofactor
   Cellular cofactor concentration important cell              perturbations Escherichia coli. J. Biol. Chem. 285:17498â€“17506.
redox biocatalysis (4, 6), determines biocat-        14. Hou, J., G. Scalcinati, M. Oldiges, G. N. Vemuri. 2010. Metabolic impact
alyst operates effectively given condition. cellular        increased NADH availability Saccharomyces cerevisiae. Appl. Environ.
                                                                           Microbiol. 76:851â€“859.
NAD(H) concentration lower Km, biocatalyst          15. Hove-Jensen, B. 1996. Phosphoribosyl diphosphate synthetase-independent working optimal condition, based                   NADâ«¹ novo synthesis Escherichia coli: new phenotype phosphate
sumption apparent kinetics NAD(H) follows                  regulon mutants. J. Bacteriol. 178:714â€“722.
                                                                       16. Knepper, , M. Schleicher, M. Klauke, M. Weuster-Botz. 2008. 
classic rate equation V â«½ Vmax [NAD(H)]/(Km â«¹ [NAD(H)]).                   hancement NAD(P)(H) pool Saccharomyces cerevisiae. Eng. Life  determination apparent kinetics NAD(H)                Sci. 8:381â€“389.
                                                                       17. Koebmann, B. J., H. V. Westerhoff, J. L. Snoep, D. Nilsson, P. R. Jensen. necessary optimizing designing biocatalysts.             2002. glycolytic flux Escherichia coli controlled demand difficult acquire apparent kinetics data using                ATP. J. Bacteriol. 184:3909â€“3916.
wild-type cells, self-regulation mechanism limits          18. Kratzer, R., et al. 2011. Enzyme identification development 
                                                                           cell biotransformation asymmetric reduction o-chloroacetophenone. fluctuation cellular cofactor